Skip to main content
. Author manuscript; available in PMC: 2010 Apr 1.
Published in final edited form as: Cancer. 2009 Apr 1;115(7):1498–1506. doi: 10.1002/cncr.24157

Table 4.

Joint Effects between Genotypes and Smoking Status for OPLs

Genotype Exposure Status Controls (%) Cases (%) Adjusted OR (95% CI)* Pinteraction
Smoking status
COX-2 −765G>C, rs20417
WM+MM No 28 (19.44) 17 (12.69) 1.00 (ref.)
WM+MM Yes 26 (18.06) 20 (14.93) 1.29 (0.55−3.06)
WW No 51 (35.42) 26 (19.40) 0.77 (0.35−1.68)
WW Yes 39 (27.08) 71 (52.99) 2.99 (1.43−6.23) 0.041
COX-2 exon 10 +837T>C, rs5275
WM+MM No 54 (37.24) 25 (18.38) 1.00 (ref.)
WM+MM Yes 41(28.28) 41 (30.15) 2.22 (1.15−4.29)
WW No 26 (17.93) 19 (13.97) 1.53 (0.71−3.31)
WW Yes 24 (16.55) 51 (37.50) 4.95 (2.48−9.91) 0.465
COX-2 exon 10 −90C>T, rs68479
WM+MM No 10 (6.90) 1 (0.74) 1.00 (ref.)
WM+MM Yes 3 (2.07) 4 (2.94) 14.73 (1.12−192.90)
WW No 70 (48.28) 43 (31.62) 6.24 (0.76−51.33)
WW Yes 62 (42.76) 88 (64.71) 15.60 (1.91−127.63) 0.184

OR indicates odds ratio; CI, confidence interval; COX-2, cyclooxygenase-2 gene; rs, reference single-nucleotide polymorphism; WM, heterozygous genotype; MM, homozygous variant genotype; WW, homozygous wild-type genotype.

*

Adjusted for gender and age.